CYP2A6*4 allele gene high frequency associated with low-density lipoprotein cholesterol (LDL-C) among Javanese Indonesian smokers

Preiffer Agus Prasojo, Christine Patramurti

Abstract


The CYP2A6 gene, which codes the CYP2A6 enzyme, has known to have ahigh polymorphism. This polymorphism could decrease, increase, or eliminate the CYP2A6 enzyme activity. CYP2A6*4, an inactive allele, decreased the CYP2A6 enzyme activity. One of the CYP2A6 enzyme-specific substrates is nicotine. This inactive allele could decrease nicotine metabolism that causes high nicotine levels in the blood. In addition, it caused the increasing levels of Low-Density Lipoprotein Cholesterol (LDL-C) by expanding the lipolysis process. The purpose of this research was to evaluate the effect of the CYP2A6*4 allele gene on LDL-C levels. Respondents in this study were 31 male Javanese smokers. This research is an analytic observational study with a cross-sectional design. Polymerase chain reaction (PCR) methods use to identification the CYP2A6*4 allele gene. This study shows that a high-frequency CYP2A6*4 alleles gene among the subject was detected, with an allele frequency is 93.55%. Furthermore, this CYP2A6*4 allele gene did not impact LDL-C levels, with the Odd Ratio value was 1.636 (P-Value = 0.737). In conclusion, the CYP2A6*4 allele gene does not significantly affect the LDL-C levels in Javanese Indonesian smokers.


Keywords


cardiovascular disease; CYP2A6; Javanese male; LDL-C; and polymorphism

Full Text:

PDF

References


Akrodou, Y. M. (2015). CYP2A6 polymorphisms may strengthen individualized treatment for nicotine dependence. Scientifica, 1(1), 1–7. https://doi.org/10.1155/2015/491514

Alessandro, A. D., Boeckelmann, I., Goette, A., & Hammwho, M. (2011). Nicotine , cigarette smoking and cardiac arrhythmia : an overview. European Journal of Preventive Cardiology, 19(3), 297–305. https://doi.org/10.1177/1741826711411738

Bajaj, M. (2012). Nicotine and insulin resistance: when the smoke clears. Diabetes, 61(12), 3078–3080. https://doi.org/10.2337/db12-1100

Benowitz, L, N., Helen, G., Dempsey, D., Jacob, P., & Tyndale, R. (2016). Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity. Pharmacogenet Genomics, 26(7), 1–22. https://doi.org/10.1097/FPC.0000000000000222.Disposition

Benowitz, N. L. (2011). Smokeless tobacco as a nicotine delivery device: Harm or harm reduction? Clinical Pharmacology and Therapeutics, 90(4), 491–493. https://doi.org/10.1038/clpt.2011.191

Breitling, L. (2013). Related cardiovascular disease genetic determination of nicotine dependence. Arterioscler Thromb Vasc Biol, 33, 1468–1472. https://doi.org/10.1161/ATVBAHA.112.300157

Devaranavadgi, B., Aski, B., Kashinath, R., & Hundekari, I. (2012). Effect of cigarette smoking on blood lipids – A study in belgaum, northern karnataka, India. Global Journal of Medical Research, 12(6), 57–61. https://doi.org/10.1586/edm.09.33

Di, Y., Chow, V., Yang, L.-P., & Zhou, S.-F. (2010). Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Current Drug Metabolism, 10(7), 754–780. https://doi.org/10.2174/138920009789895507

Fukami, T., Nakajima, M., Yamanaka, H., Fukushima, Y., McLeod, H., & Yokoi, T. (2007). Short communication a novel duplication type of CYP2A6 gene in African-American abstract : The American Society for Pharmacology and Experimental Therapeutics, 35(4), 515–520. https://doi.org/10.1124/dmd.106.013557.al

Gitaningtyas, E. (2018). Identifikasi alel CYP2A6*4 pada isolat DNA perokok ras kulit hitam Papua Indonesia dengan metode polymerase chain reaction. Universitas Sanata Dharma

Heatherton, T. D., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The_Fagerstrom_Test_for_Nicotine_Dependence_A_Revi.pdf. British Journal of Addiction, 86(9), 1119–1127

Kemenkes RI. (2018). Riskesdas 2018.

Liu, T., David, S. P., Tyndale, R. F., Wang, H., Zhou, Q., Ding, P., He, Y., Yu, X., Chen, W., Crump, C., & Wen, X. (2011). Associations of CYP2A6 genotype with smoking behaviors in southern China. NIH Public Access, 106(5), 985–994. https://doi.org/10.1111/j.1360-0443.2010.03353.x.Associations

Messner, B., & Bernhard, D. (2014). Smoking and cardiovascular disease: Mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(3), 509–515. https://doi.org/10.1161/ATVBAHA.113.300156

Minarti, N, S., Ketaren, I., & Hadi, P, D. (2014). Hubungan antara perilaku merokok terhadap kadar kolesterol low density lipoprotein (LDL) serum pada pekerja cv. Julian Pratama Pontianak. UNTAN, 1(1), 1–17.

Minematsu, N., Nakamura, H., Furuuchi, M., Nakajima, T., Takahashi, S., Tateno, H., & Ishizaka, A. (2006). Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms. The European Respiratory Journal, 27(2), 289–292. https://doi.org/10.1183/09031936.06.00056305

Mishra, A., Chaturvedi, P., Datta, S., Sinukumar, S., Joshi, P., & Garg, A. (2015). Harmful effects of nicotine. Indian Journal of Medical and Paediatric Oncology, 36(1), 24–31. https://doi.org/10.4103/0971-5851.151771

Murtiyaningsih, H. (2017). Isolasi DNA genom dan identifikasi kekerabatan genetik nanas menggunakan RAPD (Random Amplified Polimorfic DNA). Agritrop, 15(1), 1–10.

Mwenifumbo, J. C., Al Koudsi, N., Ho, M. K., Zhou, Q., Hoffmann, E. B., Sellers, E. M., & Tyndale, R. F. (2008). Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Human Mutation, 29(5), 679–688. https://doi.org/10.1002/humu.20698

Mwenifumbo, J. C., & Tyndale, R. F. (2007). Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics, 8(10), 1385–1402. https://doi.org/10.2217/14622416.8.10.1385

Nakajima, M., Fukami, T., Yamanaka, H., Higashi, E., Sakai, H., Yoshida, R., Kwon, J., Mcleod, H. L., & Yokoi, T. (2006). Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. 80(3), 282–297.https://doi.org/10.1016/j.clpt.2006.05.012

Akrodou, Y. M. (2015). CYP2A6 polymorphisms may strengthen individualized treatment for nicotine dependence. Scientifica, 1(1), 1–7. https://doi.org/10.1155/2015/491514

Alessandro, A. D., Boeckelmann, I., Goette, A., & Hammwho, M. (2011). Nicotine , cigarette smoking and cardiac arrhythmia : an overview. European Journal of Preventive Cardiology, 19(3), 297–305. https://doi.org/10.1177/1741826711411738

Bajaj, M. (2012). Nicotine and insulin resistance: when the smoke clears. Diabetes, 61(12), 3078–3080. https://doi.org/10.2337/db12-1100

Benowitz, L, N., Helen, G., Dempsey, D., Jacob, P., & Tyndale, R. (2016). Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity. Pharmacogenet Genomics, 26(7), 1–22. https://doi.org/10.1097/FPC.0000000000000222.Disposition

Benowitz, N. L. (2011). Smokeless tobacco as a nicotine delivery device: Harm or harm reduction? Clinical Pharmacology and Therapeutics, 90(4), 491–493. https://doi.org/10.1038/clpt.2011.191

Breitling, L. (2013). Related cardiovascular disease genetic determination of nicotine dependence. Arterioscler Thromb Vasc Biol, 33, 1468–1472. https://doi.org/10.1161/ATVBAHA.112.300157

Devaranavadgi, B., Aski, B., Kashinath, R., & Hundekari, I. (2012). Effect of cigarette smoking on blood lipids – A study in belgaum, northern karnataka, India. Global Journal of Medical Research, 12(6), 57–61. https://doi.org/10.1586/edm.09.33

Di, Y., Chow, V., Yang, L.-P., & Zhou, S.-F. (2010). Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Current Drug Metabolism, 10(7), 754–780. https://doi.org/10.2174/138920009789895507

Fukami, T., Nakajima, M., Yamanaka, H., Fukushima, Y., McLeod, H., & Yokoi, T. (2007). Short communication a novel duplication type of CYP2A6 gene in African-American abstract : The American Society for Pharmacology and Experimental Therapeutics, 35(4), 515–520. https://doi.org/10.1124/dmd.106.013557.al

Gitaningtyas, E. (2018). Identifikasi alel CYP2A6*4 pada isolat DNA perokok ras kulit hitam Papua Indonesia dengan metode polymerase chain reaction. Universitas Sanata Dharma

Heatherton, T. D., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The_Fagerstrom_Test_for_Nicotine_Dependence_A_Revi.pdf. British Journal of Addiction, 86(9), 1119–1127

Kemenkes RI. (2018). Riskesdas 2018.

Liu, T., David, S. P., Tyndale, R. F., Wang, H., Zhou, Q., Ding, P., He, Y., Yu, X., Chen, W., Crump, C., & Wen, X. (2011). Associations of CYP2A6 genotype with smoking behaviors in southern China. NIH Public Access, 106(5), 985–994. https://doi.org/10.1111/j.1360-0443.2010.03353.x.Associations

Messner, B., & Bernhard, D. (2014). Smoking and cardiovascular disease: Mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(3), 509–515. https://doi.org/10.1161/ATVBAHA.113.300156

Minarti, N, S., Ketaren, I., & Hadi, P, D. (2014). Hubungan antara perilaku merokok terhadap kadar kolesterol low density lipoprotein (LDL) serum pada pekerja cv. Julian Pratama Pontianak. UNTAN, 1(1), 1–17.

Minematsu, N., Nakamura, H., Furuuchi, M., Nakajima, T., Takahashi, S., Tateno, H., & Ishizaka, A. (2006). Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms. The European Respiratory Journal, 27(2), 289–292. https://doi.org/10.1183/09031936.06.00056305

Mishra, A., Chaturvedi, P., Datta, S., Sinukumar, S., Joshi, P., & Garg, A. (2015). Harmful effects of nicotine. Indian Journal of Medical and Paediatric Oncology, 36(1), 24–31. https://doi.org/10.4103/0971-5851.151771

Murtiyaningsih, H. (2017). Isolasi DNA genom dan identifikasi kekerabatan genetik nanas menggunakan RAPD (Random Amplified Polimorfic DNA). Agritrop, 15(1), 1–10.

Mwenifumbo, J. C., Al Koudsi, N., Ho, M. K., Zhou, Q., Hoffmann, E. B., Sellers, E. M., & Tyndale, R. F. (2008). Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Human Mutation, 29(5), 679–688. https://doi.org/10.1002/humu.20698

Mwenifumbo, J. C., & Tyndale, R. F. (2007). Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics, 8(10), 1385–1402. https://doi.org/10.2217/14622416.8.10.1385

Nakajima, M., Fukami, T., Yamanaka, H., Higashi, E., Sakai, H., Yoshida, R., Kwon, J., Mcleod, H. L., & Yokoi, T. (2006). Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. 80(3), 282–297. https://doi.org/10.1016/j.clpt.2006.05.012

Patramurti, C, & Fenty. (2017). Studi genotipe sitokrom P450 2A6 Alel CYP2A6 * 4 dan CYP2A6 * 9 pada subyek uji perokok suku Jawa Indonesia ( Genotyping Study of Cytochrome P450 2A6 Alel CYP2A6 * 1 and CYP2A6 * 9 among Javanese Indonesian Smokers ). Jurnal Ilmu Kefarmasian Indonesia, 15(1), 50–56

Patramurti, C, & Fenty. (2020). Association between smoking behaviour and glycohemoglobine. Jurnal Farmasi Sains Dan Komunitas, 17(2), 76–85

Patramurti, Christine, . S., Nurrochmad, A., & Martono, S. (2015). Polymorphism of Cytochrome P450 2a6 (Cyp2a6*1 and Cyp2a6*4) Among Javanese Indonesian Smoker and Non Smoker. Indonesian Journal of Pharmacy, 26(1), 11–19. https://doi.org/10.14499/indonesianjpharm26iss1pp11

Patramurti, Christine, Martono, S., Sugiyanto, S., & Nurrochmad, A. (2017). Inter-individual variability of cytochrome P450 2A6 activity in Javanese Smokers’ urine. Media Penelitian Dan Pengembangan Kesehatan, 27(3), 133–140. https://doi.org/10.22435/mpk.v27i3.4777.133-140

Patramurti, & Fenty. (2019). Genetic Polymorphism Cytochrome P4502a6 Allel *4 And *9: Studi On Glycohemoglobine Level Among Javanese Indonesian Smokers. Pharmaceutical Sciences and Research, 6(2), 82–88. https://doi.org/10.7454/psr.v6i2.4488

Pelt-Verkuil, E, V., Belkum, Van, A., Hays, & P., J. (2008). Principles and technical aspects of PCR amplification. Springer Netherlands

Perhimpunan Dokter Hipertensi Indonesia. (2019). Konsensus penatalaksanaan hipertensi 2019 (L. Anna, H. Eka, & M. Hustrini (eds.)).

Rao, & Subash. (2013). The effect of chronic tobacco smoking and chewing on the lipid profile. Journal of Clinical and Diagnostic Research, 7(1), 31–34. https://doi.org/10.7860/JCDR/2012/5086.2663

Sanhia, A. M., Pangemanan, D., & Engka, J. N. (2015). Gambaran kadar kolesterol low density lipoprotein. E-Biomedik(EBm), 3(April), 460–465

Schoedel, K. a, Hoffmann, E. B., Rao, Y., Sellers, E. M., & Tyndale, R. F. (2004). Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics, 14(9), 615–626. https://doi.org/10.1097/00008571-200409000-00006

Singh, D, P., Gulati, D., & Singh, P. (2016). Smoking and its association with serum lipid levels. International Journal of Medical Research and Review, 4(11), 2064–2070. https://doi.org/10.17511/ijmrr.2016.i11.28

Tanner, A, J., Henderson, A, J., Buchwald, D., Howard, V, B., Henderson, N, P., & Tyndale, F, R. (2017). Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer. Pharmacogenet Genomics, 27(5), 169–178. https://doi.org/10.1016/j.physbeh.2017.03.040

TCSC-IAKMI. (2020). Atlas Tembakau Indonesia 2020

Watanabe, N., Fukushima, M., Taniguchi, A., Okumura, T., Nomura, Y., Nishimura, F., Aoyama, S., Yabe, D., Izumi, Y., Ohtsubo, R., Nakai, Y., & Nagasaka, S. (2011). Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance. Tobacco Induced Diseases, 9(1), 12. https://doi.org/10.1186/1617-9625-9-12

World Health Organization. (2014). Indonesia

World Health Organization. (2017). Cardiovascular Disease Risk Factor

World Health Organization. (2020). Tobacco

Yusof, W., & Gan, S. H. (2009). High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population. Clinica Chimica Acta, 403(1–2), 105–109. https://doi.org/10.1016/j.cca.2009.01.032




DOI: http://dx.doi.org/10.12928/pharmaciana.v11i2.20744

Article Metrics

Abstract view : 0 times
PDF - 0 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 preiffer agus prasojo, Christine Patramurti

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


 
Pharmaciana
ISSN Print: 2088-4559 | ISSN Online: 2477-0256
Website: http://journal.uad.ac.id/index.php/PHARMACIANA
Office: Faculty of  Pharmacy, Universitas Ahmad Dahlan
Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta, Indonesia
Kode pos 55164
Email: pharmaciana@pharm.uad.ac.id